Bi Chao-Ran, Jing Wei, Xie Xiao-Fei, Liu Yan-Jing
College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, 1035 Boshuo Road, Changchun, China.
Children's Diagnosis and Treatment Center, Affiliated Hospital to ChangChun University of Chinese Medicine, 1478 Gongnong Road, Changchun, China.
Trials. 2021 Jun 29;22(1):426. doi: 10.1186/s13063-021-05381-8.
Bacterial infection is an important cause of diarrhea in children, potentially leading to malnutrition, growth and development disorders, and even death. Antibiotic abuse and resistance are widespread problems worldwide, especially in China. We therefore designed a study to evaluate the clinical efficacy and mechanism of traditional Chinese medicine in alleviating the effects of antibiotic resistance in childhood bacterial diarrhea and enhancing the sensitivity of pathogenic bacteria to antibiotics.
This randomized, double-blind, placebo-controlled clinical trial has completed ChiCTR registration. The trial will randomly divide 120 children who meet the inclusion criteria into three groups: experimental group 1 (basic treatment + Gegen Qinlian decoction granules + Erbai drink placebo), experimental group 2 (basic treatment + Erbai drink granules + Gegen Qinlian decoction placebo), and control group (basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo). The main efficacy indicators will be antibiotic use rate and clinical cure rate, and the secondary efficacy indicators will be time to antibiotic intervention, effective rate, and course of treatment determined after 5 days. The following physical and chemical indicators will be measured: routine blood parameters, procalcitonin, C-reactive protein, electrocardiogram, liver and kidney function, electrolytes, routine urinalysis, routine stool analysis, and stool culture (including drug sensitivity).
The results of this study may provide an objective clinical basis for the use of traditional Chinese medicine in managing antibiotic-resistant bacterial diarrhea in children, formulating relevant guidelines, and demonstrating the use of traditional Chinese medicine for reducing the use of antibiotics.
Chinese Clinical Trial Registry ChiCTR1900027915 . Last refreshed on December 4, 2019.
细菌感染是儿童腹泻的重要原因,可能导致营养不良、生长发育障碍,甚至死亡。抗生素滥用和耐药性是全球普遍存在的问题,在中国尤为突出。因此,我们设计了一项研究,以评估中药在减轻儿童细菌性腹泻抗生素耐药性影响及增强病原菌对抗生素敏感性方面的临床疗效和作用机制。
这项随机、双盲、安慰剂对照的临床试验已完成中国临床试验注册。该试验将把120名符合纳入标准的儿童随机分为三组:实验组1(基础治疗+葛根芩连汤颗粒+二白饮安慰剂)、实验组2(基础治疗+二白饮颗粒+葛根芩连汤安慰剂)和对照组(基础治疗+葛根芩连汤安慰剂+二白饮安慰剂)。主要疗效指标为抗生素使用率和临床治愈率,次要疗效指标为抗生素干预时间、有效率以及5天后确定的疗程。将测量以下理化指标:血常规、降钙素原、C反应蛋白、心电图、肝肾功能、电解质、尿常规、粪便常规分析及粪便培养(包括药敏试验)。
本研究结果可能为中药用于治疗儿童抗生素耐药性细菌性腹泻、制定相关指南以及证明中药减少抗生素使用提供客观的临床依据。
中国临床试验注册中心ChiCTR1900027915。最后更新于2019年12月4日。